No Data
No Data
JiangXi Tianxin Pharmaceutical's (SHSE:603235) Earnings Are Built On Soft Foundations
Tianxin Pharmaceutical's chairman has been placed under coercive measures and resigned as the company's legal representative in June | Quick read announcement
①Tonight, Tianxin Pharmaceutical announced that its actual controller and chairman, Xu Jiangnan, has been detained for investigation; ②In June this year, Xu Jiangnan resigned as the legal representative of the company; ③Since the middle of last year, dozens of pharmaceutical company chairmen and executives have been detained or investigated, and some have been released from detention.
Gelonghui announcement highlights | Byd: 1-10 months passenger vehicle sales reached 3.237 million vehicles, a year-on-year increase of 36.5%; Chongqing Sokon Industry Group Stock: In October, Chongqing Sokon Industry Group Stock car sales reached 33,921
[Company Business Data] Great Wall Motor (601633.SH): Total sales in October reached 116,799 units, a year-on-year decrease of 11.05%. BYD Company Limited (002594.SZ): Passenger vehicle sales from January to October reached 3.237 million vehicles, a year-on-year increase of 36.5%. Lifan Technology (601777.SH): Total vehicle sales in October amounted to 4,005 units, a year-on-year increase of 8.07%. *Special Treat Hanma (600375.SH): Medium and heavy-duty truck sales in October were 1050 units, a year-on-year increase of 26.96%. Chongqing Sokon Industry Group Stock (601127.SH): Sokon autos sold 33 vehicles in October.
Tasly Pharmaceutical (603235.SH): The company did not implement share repurchases in October.
Great Wisdom Report October 31st | Tianxin Pharmaceutical (603235.SH) announced that in October 2024, the company did not implement share repurchases. As of October 31, 2024, the company had repurchased a total of 2,609,720 shares, with the repurchased shares accounting for 0.5961% of the total share capital of the company. The highest repurchase price was 28.00 yuan/share, the lowest price was 19.17 yuan/share, and the total amount paid was 60,001,880.46 yuan (excluding transaction costs).
Third Quarter Report 2024
Announcement on operating data for the third quarter of 2024
No Data
No Data